(Press-News.org) A combination strategy of endoscopic ultrasound-guided radiofrequency ablation (EUS-RFA) with chemotherapy for pancreatic cancer will be studied at UTHealth Houston through a $3.3 million grant from the National Cancer Institute by the U.S. Department of Health and Human Services.
The survival rate of pancreatic adenocarcinoma, or pancreatic cancer, remains low, around 10%, because of its poor response to current chemotherapies.
The five-year grant will continue the established six-year clinical and translational research collaboration between Jennifer Bailey-Lundberg, PhD, assistant professor in the Department of Anesthesiology, Critical Care and Pain Medicine; and Nirav Thosani, MD, associate professor in the Department of Surgery, both with McGovern Medical School at UTHealth Houston.
Radiofrequency ablation therapy is the localized use of radio waves to destroy tumor tissues and reduce their growth. Shrinkage of the tumors can allow for them to be surgically removed.
The first aim of the project will evaluate the effects of chemotherapy with repeated EUS-RFA on tumor growth and long-term clinical outcomes such as survival and anti-tumor immunity mechanisms in patients with removable, or resectable, cancer of the pancreas. Researchers will build upon their published findings to follow patients already receiving the alternating standard chemotherapy and EUS-RFA versus chemotherapy treatment alone. Their evaluation will help create therapeutic potential and utility for the adoption of EUS-RFA treatment into clinical care.
“The EUS-guided radiofrequency ablation therapy is a minimally invasive and an extremely well-tolerated novel procedure that allows local control of the tumor and supports immune system response, which we hadn’t seen in any treatment before. This has the potential to change how we treat pancreatic cancer in the future,” said Thosani, who is also the Atilla Ertan, MD, Chair in Gastroenterology, Hepatology and Nutrition, and director of the Center for Interventional Gastroenterology with McGovern Medical School at UTHealth Houston.
The preclinical arm of the study aims to analyze the impact of repeated EUS-RFA treatment in sustaining immunity against tumors, and discover novel combination therapies that are targeting checkpoint blockade or immune suppression to amplify RFA-mediated anti-tumor responses.
Immune checkpoint inhibitors are cancer treatment drugs that block the binding of checkpoint proteins and their partner proteins, which are expressed on immune cells or cancer cells. Checkpoint proteins reduce the potency of cancer-fighting cells in the immune system.
Researchers will administer repeated RFA treatment to tumors in preclinical models, along with targeting immunotherapies to promote anti-tumor immune responses and tumor shrinkage. Anti-tumor immunity will be measured using comprehensive approaches to evaluate RFA and immunotherapy-dependent effects on primary tumors as well as tumors in areas of the body that did not receive direct local RFA therapy, a response called the abscopal effect.
“We want to determine if immunotherapy in combination with RFA can significantly reduce the growth rate of RFA-treated tumors and tumors in other parts of the body. In these studies, we want to enhance the RFA-dependent abscopal response to not only treat local disease, but also treat metastatic pancreatic cancer,” Bailey-Lundberg said.
Media Inquiries: 713-500-3030
END
UTHealth Houston study on repeated radiofrequency ablation in combination with chemotherapy for pancreatic cancer supported with $3.3M HHS grant
2023-06-20
[Attachments] See images for this press release:
ELSE PRESS RELEASES FROM THIS DATE:
Breast cancer research team pulls in $3 million in national support
2023-06-20
UTHSC researchers working to find new treatments to combat breast cancer metastasis recently pulled in a major national award. Wei Li, PhD, distinguished professor of Pharmaceutical Sciences and director of the Drug Discovery Center in the College of Pharmacy, and Tiffany Seagroves, PhD, professor of Pathology in the College of Medicine, are principal investigators on a $3.07 million grant from the National Cancer Institute for a project to develop a new series of drugs targeting microtubules to stop the spread of breast cancer to the brain and bone. Duane Miller, PhD, professor emeritus, and Zhongzhi Wu, PhD, assistant professor, both in ...
Science in the shadows: NASA selects 5 experiments for 2024 total solar eclipse
2023-06-20
A total solar eclipse will darken a swath of North America as the Moon blocks the light of the Sun for a few minutes on April 8, 2024. In addition to casting a breathtaking, passing shadow over the heads of millions of people, this total solar eclipse gives scientists a unique opportunity to study the Sun, Earth, and their interactions.
NASA will fund five interdisciplinary science projects for the 2024 eclipse to make the most of this opportunity. The projects, which are led by researchers at different academic institutions, will study the Sun and its influence on Earth with a variety of instruments, including cameras aboard high-altitude research planes, ham radios, and ...
Dupilumab lessens disease in COPD patients with type 2 inflammation
2023-06-20
BIRMINGHAM, Ala. – Chronic obstructive pulmonary disease patients with type 2 inflammation saw rapid and sustained improvements in their disease after treatment with the monoclonal antibody dupilumab, according to a yearlong, Phase 3 clinical trial reported in the New England Journal of Medicine.
These improvements — as measured by a significantly lower annualized rate of acute exacerbations, significantly better lung function and quality of life, and significantly less severe symptoms than placebo-treated adults with COPD — were observed within two to four weeks after the initiation of dupilumab and were sustained throughout the 52-week trial period. This monoclonal antibody ...
Scientists discover new embryonic cell type that self-destructs to protect the developing embryo
2023-06-20
Scientists studying gene activity data of the early human embryo have discovered an overlooked type of cell which self-destructs within days of forming, as part of a quality control process to protect the developing foetus. The findings give insights on what happens at the very first stages of life after fertilisation which could in the future help improve IVF or regenerative medicine treatments.
A new study published on 20 June 2023 in PLoS Biology by an international team of scientists including researchers at the University of Bath, finds that our earliest development in the womb may be rather different to what we have always assumed.
While ...
National Geographic Explorers win award for visualizing arctic climate change
2023-06-20
FOR IMMEDIATE RELEASE: June 20, 2023 - Washington, D.C. - An innovative virtual reality project created by National Geographic Explorers in collaboration with local communities was recognized with the “Best in Category: Visualize” during the XR Prize Challenge: Fight Climate Change earlier this month. The project, “Qikiqtaruk: Arctic at Risk” was selected for the award from across 150 submissions at the Augmented World Expo (AWE) in Santa Clara, California on June 1, 2023.
“Qikiqtaruk: Arctic at Risk” brought together researchers, park rangers, educators and immersive content ...
NYU Abu Dhabi researchers develop first-of-its-kind adhesive bandage that can detect COVID-19 antibodies
2023-06-20
Abu Dhabi, UAE, June 20, 2023: Researchers at NYU Abu Dhabi have developed a new rapid testing method for COVID-19 – an adhesive bandage that relies on gold nanoparticles to quickly detect the immune antibodies in the bloodstream.
These antibodies, named IgM and IgG, are naturally produced as a result of SARS-CoV-2 infection, and therefore serve as valuable biomarkers to identify infected individuals and monitor the spread of pandemics. The innovative bandage technology is affordable and easy-to-use, and ...
Alissa Park appointed Dean of UCLA Henry Samueli School of Engineering and Applied Science
2023-06-20
Ah-Hyung “Alissa” Park has been appointed the Ronald and Valerie Sugar Dean of the UCLA Henry Samueli School of Engineering and Applied Science, effective September 1.
One of the nation’s leading experts on carbon capture and conversion technology, Park is currently the Lenfest Earth Institute Professor of Climate Change and chair of the department of earth and environmental engineering at Columbia University, where she has been a faculty member since 2007. She also is director of the Lenfest Center for Sustainable Energy, an executive committee ...
Research identifies factors that make correcting misinformation about science more successful
2023-06-20
In an article titled “A Meta-analysis of Correction Effects in Science-Relevant Misinformation” published in the journal Nature Human Behaviour, University of Pennsylvania social psychologists and communication scholars Man-pui Sally Chan and Dolores Albarracín explain the circumstances under which corrections of misinformation about science are most likely to work or fail, as well as the characteristics of the corrections most likely to succeed.
The authors conducted a meta-analysis, a quantitative synthesis of prior research, which involved 60,000 ...
Wider access to health insurance via Medicaid expansion improved cardiac care
2023-06-20
Research Highlights:
States that participated in the Medicaid expansion provision of the Affordable Care Act, raising the income level to be eligible for Medicaid up to 138% of the federal poverty level, improved several measures of heart disease care for Medicaid recipients in their states.
In an analysis of 30 studies comparing states that chose to participate in Medicaid expansion with those that didn’t, Medicaid expansion was associated with improvement in insurance coverage for cardiac care, decreased out-of-hospital deaths, fewer socioeconomic and demographic disparities in care and increased preventive care and screening.
Embargoed until 1 p.m. CT/2 p.m. ET, ...
Less-invasive cardiac MRI is a valuable diagnostic tool in the early evaluation of patients with acute chest pain
2023-06-20
WINSTON-SALEM, N.C. – June 20, 2023 – An estimated 3 million patients visit emergency departments each year with acute chest pain and mildly elevated troponin levels. High levels of troponin, a protein, occur when the heart muscle is damaged from a heart attack. How best to evaluate and treat patients with chest pain with detectable or mildly elevated troponin remains unclear.
Now, a new study from researchers at Wake Forest University School of Medicine reveals that cardiac magnetic resonance imaging (MRI), is a safe and valuable tool to help evaluate these complex patients.
The ...